FDA Adverse Event Injury Summary report: N

TOTAL ASR ACET IMP SIZE 52

MDR report key: 2982848 · Received February 28, 2013

Report

Report Number
1818910-2013-03016
Event Type
Injury
Date Received
February 28, 2013
Date of Event
January 31, 2013
Report Date
August 12, 2014
Manufacturer
DEPUY INTERNATIONAL LTD. 8010379
Product Code
KWA
Removal / Correction Number
Z- 1749/1816-2011
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
SF
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. REF. (B)(4). DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED. THE CORRECTION/REMOVAL REPORTING NUMBER LISTED APPLIES TO THE CORRESPONDING PRODUCT CODE SOLD DOMESTICALLY.

Additional Manufacturer Narrative · 1

IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE. DEPUY STILL CONSIDERS THIS CASE CLOSED TO CAPA.

Description of Event or Problem · 1

ASR REVISION. LEFT. ASR XL. REASON(S) FOR REVISION: PAIN.

Description of Event or Problem · 1

NEW (B)(6) RECORD CREATED IN ORDER TO UPDATE (B)(6) (LEGACY SYSTEM) COMPLAINT NUMBER (B)(4). REASON FOR ORIGINAL COMPLAINT - ASR REVISION DUE TO TAKE PLACE ON (B)(6) 2013. LEFT ASR XL. REASON(S) FOR REVISION: PAIN. UPDATE: ADDED REVISION DATE. RECEIVED: FEBRUARY 21ST 2013. UPDATE RECEIVED: 12TH AUGUST 2014 - ADDED SURGEON TITLE: DR, MARKED AS LEGAL, LEFT NOTE AND ADDED (B)(6) REFERENCE NUMBER.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
87744 TOTAL ASR ACET IMP SIZE 52 HIP ACETABULAR CUP KWA DEPUY INTERNATIONAL LTD. 8010379 2362006

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention